Publications

May 2023 (Revised June 2023)
Case

Novartis (A): Reimagining Medicine

By: Ramon Casadesus-Masanell, Claudio Feser, Karolin Frankenberger and David Redaschi

This case unfolds around the first-ever approved personalized cancer treatment, how Novartis wrapped it into a new business model design, and how Novartis scaled it. Novartis — one of the largest pharmaceutical companies in the world — is, among other ventures,... View Details

Keywords: Health Care and Treatment; Business Model; Leadership; Pharmaceutical Industry; Switzerland

January 2023
Case

Cleave Therapeutics: Taking a Risk on Oncology Drug Discovery

By: Regina Herzlinger and Brian Walker

What should a successful executive (HBS Baker Scholar) assess as her next move as the CEO of a firm with a promising and yet uncertain new drug? Amy Burroughs’ mandate to successfully commercialize Cleave Therapeutics’ drug for a cancer with no current successful... View Details

Keywords: Product Development; Leadership; Health Testing and Trials; Research and Development; Risk and Uncertainty; Financial Condition; Partners and Partnerships; Pharmaceutical Industry

02 May 2017
First Look

First Look at New Research: May 2, 2017

showing a passenger being dragged from a plane. Of all the U.S. air carriers, United should have known the power of social media and public outrage. It had learned years... View Details

Keywords: Carmen Nobel

May 2009 (Revised October 2009)
Case

Newton-Wellesley Hospital

By: Richard M.J. Bohmer and Natalie Kindred

How will Newton-Wellesley Hospital (NWH) preserve its private practice tradition while remaining effective and competitive in a healthcare industry demanding increasing integration between physicians and hospitals? This is the decision facing Newton-Wellesley Hospital... View Details

Keywords: Business Model; Profit; Health Care and Treatment; Growth and Development Strategy; Organizational Change and Adaptation; Organizational Structure; Competitive Strategy; Integration; Health Industry; Massachusetts

01 Feb 2000
News

The Future Is Now: 21st-Century Business Pondered at HBS Forum

remarks, Porter noted two potential threats to America in its current role as the standard bearer of global commerce: U.S. capital markets could get too near-term oriented, and... View Details

September 2012 (Revised August 2015)
Case

Shanghai Pharmaceuticals

By: Regina E. Herzlinger and Natalie Kindred

Shanghai Pharmaceuticals (SPH), a vertically integrated Chinese pharmaceutical conglomerate, was considering its strategic options in the context of a rapidly evolving industry, policy, and economic environment. The company—essentially a collection of subsidiaries... View Details

Keywords: Business Subsidiaries; Business Conglomerates; Vertical Integration; Decision Choices and Conditions; Mergers and Acquisitions; Consolidation; Health Care and Treatment; Global Strategy; State Ownership; Pharmaceutical Industry; Health Industry; Shanghai; United States; Europe

10 AM – 11 AM EDT, 22 Oct 2015
Webinars: Trending@HBS

Collective Impact: An Innovative Approach to Improving Public Education

In this webinar, Professor Grossman will describe an innovative approach to improving public education Collective Impact and how you can get involved to help transform public education in the communities you care about. View Details

May 2023 (Revised June 2023)
Supplement

Novartis (B): Reimagining Medicine

By: Ramon Casadesus-Masanell, Claudio Feser, Karolin Frankenberger and David Redaschi

This case unfolds around the first-ever approved personalized cancer treatment, how Novartis wrapped it into a new business model design, and how Novartis scaled it. Novartis — one of the largest pharmaceutical companies in the world — is, among other ventures,... View Details

Keywords: Health Care and Treatment; Business Model; Production; Business Strategy; Pharmaceutical Industry

Research Summary

Health-care Applications

Active postmarketing drug surveillance. There is substantial interest within the U.S. health community and among health policymakers in developing a surveillance system that scans public health databases in order to proactively detect potential drug safety... View Details

16 Dec 2014
First Look

First Look: December 16

and exit from the U.S. energy sector. The model's quantitative implications match a range of moments not targeted in View Details

Keywords: Sean Silverthorne

2024
Working Paper

Gastrointestinal Endoscopy--Without Cutting In: Case Histories of Transformational Advances

By: Amar Bhidé, Srikant M. Datar and Katherine Stebbins

This case history describes how endoscopy transformed the diagnosis of ulcers, cancerous polyps, and other alimentary canal diseases and enabled “minimally invasive” surgeries to treat such diseases. Specifically, we chronicle how: 1) flexible glass fiber endoscopes... View Details

Keywords: Health Care and Treatment; Technological Innovation; Innovation Strategy; Technology Adoption; Collaborative Innovation and Invention; Innovation and Invention; Governing Rules, Regulations, and Reforms

SSRN

Read Now

28 Feb 2013
News

Q&A: Charlie Rose Talks to Harvard's Michael Porter

30 Oct 2012
First Look

First Look: October 30

salary allocations to online ad clicks to admission decisions. Working PapersSecurities Litigation Risk for Foreign Companies Listed in the U.S. Authors:Beiting Cheng, Suraj... View Details

Keywords: Sean Silverthorne

20 Nov 2018
First Look

New Research and Ideas, November 20, 2018

Abstract—In a survey of the NEJM Catalyst Insights Council in July 2018, 42% of respondents say they think value-based reimbursement models will be the primary revenue model... View Details

Keywords: Dina Gerdeman

Web

Letter from Dean Srikant Datar to the HBS Community on Ukraine | About

about these, and other thought pieces and events, in the days ahead via myHBS. If you wish to talk to someone, students can reach out to SAS staff (617.495.6087 or sas@hbs.edu 8am-5pm weekdays) or CAMHS... View Details

27 Sep 2011
First Look

First Look: September 27

Industry Author:Arthur Daemmrich Abstract Fiercely contested before, during, and since its passage, the 2010 Patient Protection and Affordable Care Act (ACA) will restructure View Details

Keywords: Sean Silverthorne

05 Jun 2006
Research & Ideas

Using Competition to Reform Healthcare

The ills of the U.S. healthcare system are well chronicled—soaring costs, low customer satisfaction, increasing problems with quality, and restricted coverage lead View Details

Keywords: by Michael E. Porter; Health

September 1991 (Revised February 1993)
Case

Burroughs Wellcome and AZT (A)

By: Willis M. Emmons III

Burroughs Wellcome Co., developer of AZT, the first drug approved by the U.S. Food and Drug Administration for the treatment of Acquired Immune Deficiency Syndrome (AIDS), finds itself under siege in September 1989 by AIDS activists and various segments of the U.S.... View Details

Keywords: Governing Rules, Regulations, and Reforms; Ethics; Business and Government Relations; Communication Strategy; Health Care and Treatment; Monopoly; Intellectual Property; Research and Development; Price; Pharmaceutical Industry; London